ID: ALA3144191

Max Phase: Preclinical

Molecular Formula: C15H17N2O9P

Molecular Weight: 400.28

Molecule Type: Small molecule

Representations

Canonical SMILES:  O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O)O2)cc1-c1ccc(O)cc1

Standard InChI:  InChI=1S/C15H17N2O9P/c18-9-3-1-8(2-4-9)10-6-17(15(21)16-14(10)20)13-5-11(19)12(26-13)7-25-27(22,23)24/h1-4,6,11-13,18-19H,5,7H2,(H,16,20,21)(H2,22,23,24)/t11-,12+,13+/m0/s1

Standard InChI Key:  FITQCXBNGAYEHX-YNEHKIRRSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 400.28

Molecular Weight (Monoisotopic): 400.0672

AlogP: -0.33

#Rotatable Bonds: 5

Polar Surface Area: 171.31

Molecular Species: ACID

HBA: 8

HBD: 5

#RO5 Violations: 0

HBA (Lipinski): 11

HBD (Lipinski): 5

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 1.23

CX Basic pKa:

CX LogP: -0.27

CX LogD: -3.81

Aromatic Rings: 2

Heavy Atoms: 27

QED Weighted: 0.42

Np Likeness Score: 0.92

References

1. Chang G, Schwepler D, Decedue CJ, Balzarini J, De Clercq E, Mertes MP..  (1988)  Linear free energy relationship studies of enzyme active site binding: thymidylate synthase.,  31  (6): [PMID:3373483] [10.1021/jm00401a013]

Source

Source(1):

• Scientific Literature